脑部放疗，上午比下午敏感许多！! q: [& x( d6 `; Y# b; c1 y
8 [. D+ Q" v; q& U; \$ @" Z- }1 K8 N
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
) R& U/ u7 q; | w5 _* ZGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?1 q* E, o3 H5 ]- g; ~
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.3 V& G/ N; p2 w8 O7 v h3 H
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.9 m7 g2 a( c0 s. d+ P
0 N6 V, F; T5 T! Y: f6 i
Abstract$ N9 h: z: S5 T" k
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
" m' v, ~! X- m
0 r: C) ~; c: H- a& O3 nMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.# n# _3 O. H# s3 y$ [
5 }9 P6 A' Y1 V: X" {
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
- U& \! z0 I. p6 V" M8 p
( K$ E/ m2 y G7 F$ Z" FCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series. m! l! Q- U. @8 w# A: d2 Y/ \' d
% ?% V0 A5 v2 U1 E6 U |
; p6 k ]( z! Q: W B( s: a
显身卡
